Houston VC firm Texas Halo Fund to close fundraising for fourth fund next week

Around 40% to 50% of Texas Halo Fund's portfolio companies are in life sciences, Managing Director Rob Tucci said.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news